Bio-Works Technologies AB
Research Bio-Works Technologies AB (BIOWKS) on Bullrun: market cap SEK 336.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIOWKS
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Market capSEK 336.39M
- Financial periodQ1 2026
- RevenueSEK 29.33M
- Net incomeSEK 4.68M
- Free cash flowSEK 5.19M
- Gross margin74.6%
Valuation Snapshot
latest market cap is SEK 336.39M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 62.50M | -SEK 15.25M | -SEK 19.22M | 76.5% | -0.2 | SEK 34.93M | n/a | SEK 49.21M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 336.39M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Bio-Works Technologies AB
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bio-Works Technologies AB's market cap?
Bio-Works Technologies AB's market capitalization is SEK 336.39M.
What does Bio-Works Technologies AB do?
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins.